Back to Journals » Cancer Management and Research » Volume 11

Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer

Total article views   HTML views PDF downloads Totals
8,150 Dovepress* 6,952+ 956 7,908
PubMed Central* 1,198 385 1,583
Totals 8,150 1,341 9,491
*Since 25 October 2019
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar